Literature DB >> 7827184

Synthesis of phospholipids by human peritoneal mesothelial cells.

J Beavis1, J L Harwood, G A Coles, J D Williams.   

Abstract

OBJECTIVE: To assess the capacity of cultured human peritoneal mesothelial cells to synthesize choline-containing phospholipids. The study compares the phospholipids secreted from cultured cells with those which we, and others, have identified in the dialysate of patients treated by continuous ambulatory peritoneal dialysis (CAPD). PATIENTS: CAPD effluent was collected from 8 patients who had been receiving CAPD treatment for at least 11 months and who had normal ultrafiltration. CELL CULTURES: Using human omental tissue, homogeneous cultures of mesothelial cells were established.
METHODS: Synthesis of phospholipids by mesothelial cells was assessed following incubation with [methyl-14C] choline chloride--a precursor capable of being incorporated into phosphatidylcholine (PtdCho) and sphingomyelin. Lipids from CAPD effluent, cultured cells, and cell medium were extracted in chloroform/methanol. Phospholipids were separated and identified by thin layer chromatography. Synthesis and secretion of PtdCho and other choline-containing lipids by the mesothelial cells were determined by beta scintillation counting of the appropriate bands, while the fatty acid composition of the phospholipids was ascertained by gas liquid chromatography.
RESULTS: Synthesis and secretion of PtdCho by mesothelial cells were observed during a 96-hour period. When maintained in medium replete with essential fatty acids, the fatty acid composition of the PtdCho synthesized by cultured mesothelial cells closely resembled that isolated from the peritoneal cavity.
CONCLUSION: The demonstration of phospholipid secretion from mesothelial cells, with a fatty acid composition similar to the phospholipids isolated from peritoneal dialysate, lends added support to the hypothesis that the mesothelial cells are the source of the peritoneal phospholipids. As such they offer a useful experimental system in which to study peritoneal phospholipid synthesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7827184

Source DB:  PubMed          Journal:  Perit Dial Int        ISSN: 0896-8608            Impact factor:   1.756


  13 in total

Review 1.  Current strategies and future perspectives for intraperitoneal adhesion prevention.

Authors:  Christoph Brochhausen; Volker H Schmitt; Constanze N E Planck; Taufiek K Rajab; David Hollemann; Christine Tapprich; Bernhard Krämer; Christian Wallwiener; Helmut Hierlemann; Rolf Zehbe; Heinrich Planck; C James Kirkpatrick
Journal:  J Gastrointest Surg       Date:  2012-06       Impact factor: 3.452

Review 2.  Glucose degradation products (GDP's) and peritoneal changes in patients on chronic peritoneal dialysis: will new dialysis solutions prevent these changes?

Authors:  Murali Krishnan; Paul Tam; George Wu; Andrzej Breborowicz; Dimitrios G Oreopoulos
Journal:  Int Urol Nephrol       Date:  2005       Impact factor: 2.370

3.  Mesothelial morphology and organisation after peritoneal treatment with solid and liquid adhesion barriers--a scanning electron microscopical study.

Authors:  Christoph Brochhausen; Volker H Schmitt; Taufiek K Rajab; Constanze N E Planck; Bernhard Krämer; Christine Tapprich; Markus Wallwiener; Helmut Hierlemann; Heinrich Planck; C James Kirkpatrick
Journal:  J Mater Sci Mater Med       Date:  2012-05-10       Impact factor: 3.896

4.  Inhibition of NF-kappaB with Dehydroxymethylepoxyquinomicin modifies the function of human peritoneal mesothelial cells.

Authors:  Patrycja Sosińska; Ewa Baum; Beata Maćkowiak; Ryszard Staniszewski; Tomasz Jasinski; Kazuo Umezawa; Andrzej Bręborowicz
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

5.  Inhibition of gastric cancer cell adhesion in nude mice by inraperitoneal phospholipids.

Authors:  Marc Jansen; Karl-Heinz Treutner; Petra Lynen Jansen; Sebastian Zuber; Jens Otto; Lothar Tietze; Volker Schumpelick
Journal:  World J Surg       Date:  2005-06       Impact factor: 3.352

6.  The inhibition of tumor cell adhesion on human mesothelial cells (HOMC) by phospholipids in vitro.

Authors:  M Jansen; P Lynen Jansen; J Otto; T Kirtil; S Neuss; K-H Treutner; V Schumpelick
Journal:  Langenbecks Arch Surg       Date:  2006-03-14       Impact factor: 3.445

7.  The interstitial lymphatic peritoneal mesothelium axis in portal hypertensive ascites: when in danger, go back to the sea.

Authors:  M A Aller; I Prieto; S Argudo; F de Vicente; L Santamaría; M P de Miguel; J L Arias; J Arias
Journal:  Int J Inflam       Date:  2010-10-05

8.  Bikunin present in human peritoneal fluid is in part derived from the interaction of serum with peritoneal mesothelial cells.

Authors:  G J Thomas; S Yung; M Davies
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

9.  Phospholipids reduce the intraperitoneal adhesion of colonic tumor cells in rats and adhesion on extracellular matrix in vitro.

Authors:  Marc Jansen; Karl-Heinz Treutner; Petra Lynen Jansen; Jens Otto; Britta Schmitz; Stefan Mueller; Claudia Weiss; Lothar Tietze; Volker Schumpelick
Journal:  Int J Colorectal Dis       Date:  2004-08-12       Impact factor: 2.571

10.  Prevention of post-surgical abdominal adhesions by a novel biodegradable thermosensitive PECE hydrogel.

Authors:  Bing Yang; ChangYang Gong; ZhiYong Qian; Xia Zhao; ZhengYu Li; XiaoRong Qi; ShengTao Zhou; Qian Zhong; Feng Luo; YuQuan Wei
Journal:  BMC Biotechnol       Date:  2010-09-09       Impact factor: 2.563

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.